There are 2137 resources available
425P - Statins increase pathological response in locally advanced rectal cancer (LARC) treated with chemo-radiation (CRT): A multicentric experience
Presenter: Chiara Santini
Session: E-Poster Display
Resources:
Abstract
426P - Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study
Presenter: Francesca Negri
Session: E-Poster Display
Resources:
Abstract
427P - Value of magnetic resonance diffusion weighted imaging in the identification of complete responder patients with rectal cancer treated with neoadjuvant therapy
Presenter: Juan-ramon Ayuso
Session: E-Poster Display
Resources:
Abstract
428P - Association between three dimensional transrectal ultrasound findings and tumor response in locally advanced rectal cancer
Presenter: Ji Zhu
Session: E-Poster Display
Resources:
Abstract
429P - Feasibility and toxicity of hypofractionated radiotherapy (5x5 Gy) with a simultaneous integrated boost (5x6 Gy) in locally advanced rectal cancer
Presenter: Maciej Temnyk
Session: E-Poster Display
Resources:
Abstract
430P - Serial ctDNA (circulating tumour DNA) for detection of genomic changes during neoadjuvant chemoradiotherapy (NACRT) in locally advanced rectal cancer (LARC)
Presenter: Cha Len Lee
Session: E-Poster Display
Resources:
Abstract
431P - A randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: Updated results of JCOG1007 study (iPACS)
Presenter: Yukihide Kanemitsu
Session: E-Poster Display
Resources:
Abstract
432P - Toxicity and efficacy of 1st line cetuximab (cetux)-based therapy in RAS wildtype (WT) older patients (pts) with metastatic colorectal cancer (mCRC): A pooled analysis from 1,274 pts in the ARCAD database
Presenter: Demetris Papamichael
Session: E-Poster Display
Resources:
Abstract
434P - Impact of molecular markers status on treatment effects comparing EGFR and VEGF monoclonal antibodies (mAbs) in untreated metastatic colorectal cancer (mCRC): Pooled individual patient data (IPD) analysis of randomized trials from the ARCAD database
Presenter: Christos Karapetis
Session: E-Poster Display
Resources:
Abstract
433P - A phase Ib/II clinical trial of tolerability, safety and efficacy of regorafenib in combination with toripalimab (a PD-1 antibody) in patients with relapsed or metastatic colorectal cancer
Presenter: Feng Wang
Session: E-Poster Display
Resources:
Abstract